From NAFLD to HCC: Advances in noninvasive diagnosis

• Published in: Biomedicine & pharmacotherapy Vol. 165; p. 115028
• Main Authors: Xu, Qinchen, Feng, Maoxiao, Ren, Yidan, Liu, Xiaoyan, Gao, Huiru, Li, Zigan, Su, Xin, Wang, Qin, Wang, Yunshan
• Format: Journal Article
• Language: English
• Published: France Elsevier Masson SAS 01.09.2023
• Subjects: Fibrosis; HCC; NAFLD; NASH; Noninvasive diagnosis; TMAO; T2DM; NAFLD; TyG; TREM2; WFA+M2BP; AAT-A3F; LC-MS/MS; TERT; TGF-β; SM; PSA; FGF21; AGE; SLAMF1; Noninvasive diagnosis; EVs; UGAP; HCC; DAG; NASH; VCAM-1; CCR; CAP; RCAN2; α-TQ; Fibrosis; HOMA; TAG; B10AKR1B10

Non-alcoholic fatty liver disease (NAFLD) has gradually become one of the major liver health problems in the world. The dynamic course of the disease goes through steatosis, inflammation, fibrosis, and carcinoma. Before progressing to carcinoma, timely and effective intervention will make the condit...